Clinical Trial

Drug Interaction Study of ZYN002 Transdermal Gel and Probe Substrates

Completed Phase 1
View on ClinicalTrials.gov →
Summary
This study is an open-label drug-drug interaction (DDI) study of ZYN002 transdermal gel and multiple drugs.
Protocol Amendment History 3 amendments
This ClinicalTrials.gov record has been amended 3 times since 2025-04-09; most recent amendment 2026-02-05.
Status change: Recruiting → Completed 2026-02-05
Status change: Not Yet Recruiting → Recruiting 2025-06-27
Trial Details
NCT Number NCT06930872
Lead Sponsor Harmony Biosciences Management, Inc.
Conditions Drug Interaction
Enrollment 29 participants
Start Date 2025-06-06
Primary Completion 2025-10-04 (estimated)
Study Completion 2025-11-04 (estimated)
Updated on ClinicalTrials.gov 2026-02-09